Ion Beam Applications SA
Nathalie Depret possesses extensive experience in accounting and finance, having worked at IBA since February 2005 in various roles including Account Receivables Accountant and Consolidator Assistant. Prior to IBA, Nathalie held the position of GL Accountant at Arjo Wiggins from November 2002 to February 2005, and served in different capacities at IBA from February 1993 to November 2002, including GL Account and Trésorerie. Earlier career experience includes a role as Secrétaire - Comptable at Fiduciaire Gendarme & Cie from September 1989 to January 1993, and as a Stagiaire Onem in Services Travaux et Finances at the Administration Communale de Waterloo from September 1988 to September 1989. Nathalie Depret is an alumnus of EPHEC.
This person is not in any teams
This person is not in any offices
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.